The bane of modern India. But they are a boon for pharmaceutical companies such as Eli Lilly & Co, whose 146-year history has ...

Prime Minister Narendra Modi will meet with the CEOs of major tech companies on Sunday (September 22) during his visit to the ...

Eli Lilly has reportedly commenced Phase III clinical trials of oral medication, orforglipron, for weight loss in India. The ...

The drug is administered via injection and offers long-lasting efficacy, with a monthly maintenance dose required after the ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Two new drugs, lecanemab and donanemab, have shown the capability of slowing down the debilitating progression of Alzheimer's ...

Ashkenazi had also served as the finance chief for Lilly Research Laboratories before being appointed as the drugmaker's CFO ...

GS1 India, a supply chain standards organization set up under the ministry of commerce, Government of India, hosted the ...

Eli Lilly could launch obesity drug in India next year, CEO says Eli Lilly's CEO David Ricks told Reuters on Wednesday that the U.S. drugmaker expects to launch its obesity drug in Indian market ...

A recent health bulletin highlights critical updates including Nipah virus deaths in India's Kerala, Gaza's polio vaccination ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Lilly said it expects regulatory action for use of the drug in obesity as early as late 2023. Shares of the US drugmaker rose nearly 3 per cent before the bell. Lilly has been leaning on Mounjaro ...